Last reviewed · How we verify
PENPULIMAB-KCQX
PENPULIMAB-KCQX is a drug developed by AKESO BIOPHARMA. It is currently FDA-approved.
At a glance
| Generic name | PENPULIMAB-KCQX |
|---|---|
| Sponsor | AKESO BIOPHARMA |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
- Nausea
- Vomiting
- Hypothyroidism
- Constipation
- Decreased appetite
- Decreased weight
- Cough
- COVID-19 infection
- Fatigue
- Rash
- Pyrexia
- Anemia
Serious adverse events
- Decreased lymphocytes (Grade 3-4)
- Decreased neutrophils (Grade 3-4)
- Decreased white blood cells (Grade 3-4)
- Decreased hemoglobin (Grade 3-4)
- Decreased platelets (Grade 3-4)
- Decreased potassium (Grade 3-4)
- Increased lipase (Grade 3-4)
- Increased ALT (Grade 3-4)
- Decreased sodium (Grade 3-4)
- Increased AST (Grade 3-4)
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PENPULIMAB-KCQX CI brief — competitive landscape report
- PENPULIMAB-KCQX updates RSS · CI watch RSS
- AKESO BIOPHARMA portfolio CI
Frequently asked questions about PENPULIMAB-KCQX
What is PENPULIMAB-KCQX?
PENPULIMAB-KCQX is a pharmaceutical drug developed by AKESO BIOPHARMA.
Who makes PENPULIMAB-KCQX?
PENPULIMAB-KCQX is developed and marketed by AKESO BIOPHARMA (see full AKESO BIOPHARMA pipeline at /company/akeso-biopharma).
What development phase is PENPULIMAB-KCQX in?
PENPULIMAB-KCQX is FDA-approved (marketed).
What are the side effects of PENPULIMAB-KCQX?
Common side effects of PENPULIMAB-KCQX include Nausea, Vomiting, Hypothyroidism, Constipation, Decreased appetite, Decreased weight. Serious adverse events: Decreased lymphocytes (Grade 3-4), Decreased neutrophils (Grade 3-4), Decreased white blood cells (Grade 3-4), Decreased hemoglobin (Grade 3-4).
Related
- Manufacturer: AKESO BIOPHARMA — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing